Literature DB >> 25801981

Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomy.

Guanghua Liu1,2, Kui Wang1, Jun Li3, Yong Xia1, Lihua Lu1, Xuying Wan3, Zhenlin Yan1, Lehua Shi1, Wan Yee Lau1,4, Mengchao Wu1, Feng Shen1.   

Abstract

BACKGROUND AND AIM: To study the change in serum alpha fetoprotein (AFP) of patients with recurrent hepatocellular carcinoma (HCC) after curative resection and to analyze its effect on the survival.
METHODS: We prospectively collected 981 consecutive patients with post-resectional recurrent HCC between 2005 and 2010 at the Eastern Hepatobiliary Surgery Hospital. According to the change of AFP from the initial stage to recurrent stage, the patients were divided into stable-L (20 ng/mL to 20 ng/mL, n = 296), stable-M (20-400 ng/mL to 20-400 ng/mL, n = 102), stable-H (400 ng/mL to 400 ng/mL, n = 212), decreasing (n = 287), and increasing (n = 84) groups. The overall survival (OS) and recurrence to death survival (RTDS) were analyzed using Kaplan-Meier method. Multivariate analysis was performed by Cox proportional hazards regression.
RESULTS: The stable-H/increasing and stable-L/decreasing groups had the lowest and highest 5-year OS and RTDS rates (10.8%/18.8% vs 56.3%/55.0%; 3.4%/5.1% vs 37.7%/33.2%; both P < 0.001), while the stable-M group had the lower rates, which were 29.8% and 23.6% (for OS and RTDS: vs stable-L, P < 0.001 and 0.002; vs deceasing, P = 0.001 and 0.012; vs increasing, P = 0.113 and 0.011; vs stable-H, both P < 0.001). Cox regression analysis showed that AFP inconsistency was an independent factor affecting RTDS (decreasing vs stable-L, hazard ratio: 1.10, 95% confidence interval: 0.79-1.54, P = 0.575; increasing vs stable-L, 2.93, 2.06-4.16, P < 0.001).
CONCLUSIONS: The AFP inconsistency was an important prognostic factor for recurrent HCC.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  alpha fetoprotein; hepatectomy; hepatocellular carcinoma; recurrence

Mesh:

Substances:

Year:  2015        PMID: 25801981     DOI: 10.1111/jgh.12953

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology.

Authors:  Roberto Romero; Eunjung Jung; Tinnakorn Chaiworapongsa; Offer Erez; Dereje W Gudicha; Yeon Mee Kim; Jung-Sun Kim; Bomi Kim; Juan Pedro Kusanovic; Francesca Gotsch; Andreea B Taran; Bo Hyun Yoon; Sonia S Hassan; Chaur-Dong Hsu; Piya Chaemsaithong; Nardhy Gomez-Lopez; Lami Yeo; Chong Jai Kim; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2022-09-03       Impact factor: 10.693

2.  Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.

Authors:  Rui Liao; Cong Peng; Ming Li; De-Wei Li; Ning Jiang; Pei-Zhi Li; Xiong Ding; Qiao Wu; Cheng-You Du; Jian-Ping Gong
Journal:  Cancer Med       Date:  2018-03-13       Impact factor: 4.452

3.  Effectiveness and safety of irreversible electroporation for recurrent hepatocellular carcinoma ineligible for thermal ablation after surgery.

Authors:  Weidong Wang; Sinan Hou; JiaYan Ni; Hongliang Sun; Xiongying Jiang; Yaoting Chen; Linfeng Xu
Journal:  J Interv Med       Date:  2020-07-09

4.  Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.

Authors:  Rui Liao; Xu-Fu Wei; Ping Che; Kun-Li Yin; Lei Liu
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

5.  Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.

Authors:  Chao He; Xiaoyun Zhang; Chuan Li; Wei Peng; Tian-Fu Wen; Lv-Nan Yan; Jiayin Yang; Wusheng Lu
Journal:  Oncotarget       Date:  2017-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.